Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis

International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
Dong WangLi Guo

Abstract

Experimental autoimmune encephalitis (EAE) is an inflammatory demyelinating disease, which served as a useful model providing considerable insights into the pathogenesis of multiple sclerosis (MS). Mouse bone marrow mesenchymal stem cells (mBM-MSC) were shown to have neuroprotection capabilities in EAE. Resveratrol is a small polyphenolic compound and possess therapeutic activity in various immune-mediated diseases. The sensitivity of mBM-MSCs to resveratrol was determined by an established cell-viability assay. Resveratrol-treated mBM-MSCs were also characterized with flow cytometry using MSC-specific surface markers and analyzed for their multiple differentiation capacities. EAE was induced in C57BL/6 mice by immunization with MOG35-55. Interferon gamma (IFN-γ)/tumor necrosis factor alpha (TNF-α) and interleukin-4 (IL-4)/interleukin-10 (IL-10), the hallmark cytokines that direct T helper type 1 (Th1) and Th2 development, were detected with enzyme-linked immunosorbent assay (ELISA). In vivo efficacy experiments showed that mBM-MSCs or resveratrol alone led to a significant reduction in clinical scores, and combined treatment resulted in even more prominent reduction. The combined treatment with mBM-MSCs and resveratrol enhance...Continue Reading

References

Sep 1, 1991·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·A I Caplan
Apr 2, 1999·Science·M F PittengerD R Marshak
Feb 2, 2002·Experimental Hematology·Amelia BartholomewRonald Hoffman
Apr 17, 2002·Lancet·Alastair Compston, Alasdair Coles
Jun 5, 2002·Current Opinion in Neurology·Bernhard HemmerNorbert Sommer
Aug 19, 2004·Journal of Biomedical Materials Research. Part a·Lorenz MeinelDavid L Kaplan
Mar 18, 2005·Annual Review of Immunology·Mireia Sospedra, Roland Martin
Apr 16, 2005·Molecular Nutrition & Food Research·Catalina Alarcón de la Lastra, Isabel Villegas
May 11, 2005·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·N ElmaliB Mizrak
Jun 17, 2005·Multiple Sclerosis : Clinical and Laboratory Research·Hans H L P van den BroekRaymond M M Hupperts
Jan 4, 2006·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Z-H MaM Zhang
Apr 14, 2006·Current Medicinal Chemistry·Nazar LabinskyyZoltan Ungvari
Jun 15, 2006·Journal of Neuroscience Research·Jing ZhangMichael Chopp
Nov 23, 2006·Inflammation·N ElmaliB Mizrak
Feb 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Yuki YoshidaTohru Izumi
Apr 21, 2007·Annals of Neurology·Alberto Ascherio, Kassandra L Munger
Jul 27, 2007·Investigative Ophthalmology & Visual Science·Kenneth S ShindlerAbdolmohamad Rostami
Sep 28, 2007·Inflammation & Allergy Drug Targets·Samarjit Das, Dipak K Das
Feb 19, 2008·Nature Medicine·Ingunn M StromnesJoan M Goverman
Aug 1, 2008·Nutrition Reviews·Chibuike C UdenigwePeter J H Jones
May 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Moutih RafeiJacques Galipeau
Mar 11, 2010·Antioxidants & Redox Signaling·Lisa G WoodManohar L Garg
Dec 23, 2011·Clinical Reviews in Allergy & Immunology·Jin NakaharaNorihiro Suzuki
May 17, 2012·International Reviews of Immunology·Urban Švajger, Matjaž Jeras
Aug 15, 2015·Mediators of Inflammation·Fu-Chao LiuHuang-Ping Yu

❮ Previous
Next ❯

Citations

May 22, 2016·Clinical Reviews in Allergy & Immunology·Alexandre T J MariaPhilippe Guilpain
Feb 24, 2017·Journal of Cellular Biochemistry·Na LiJinlian Hua
May 12, 2017·Journal of Periodontology·Fernanda V RibeiroMarcio Z Casati
Sep 1, 2017·Phytotherapy Research : PTR·Mehdi DadashpourMohammad Nouri
Aug 1, 2018·Current Drug Targets·E Paul CherniackHeather F Lee
Oct 13, 2019·Reviews in the Neurosciences·Ahmed LotfyMohamed Salama
Oct 19, 2019·Stem Cell Research & Therapy·Chenxia Hu, Lanjuan Li
Aug 17, 2018·BioMed Research International·Ankit TandonRajnish Kumar Chaturvedi
Aug 4, 2019·Neurochemistry International·Leila MohtashamiBehjat Javadi
Nov 21, 2020·International Journal of Molecular Sciences·Agnese GugliandoloEmanuela Mazzon

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.